Abiopharma

🔍 Shanmugam Muthusamy (Director)

Company: ANI PHARMACEUTICALS INC (ANIP)

Report Date: 2025-08-20

Detailed Transactions and Holdings:

• Sold 47,012 shares of Common Stock at $90.27 per share (Direct)
  Date: 2025-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 484,908.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 52,988 shares of Common Stock at $90.44 per share (Direct)
  Date: 2025-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 431,920.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-20 | Code: H | shares_owned_after: 92,588.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-20 | Code: H | nature_of_ownership: Held by SS Pharma LLC | shares_owned_after: 5,000.00 | Footnotes: F4

Footnotes:

• F1: The shares were sold in multiple trades at prices ranging from $89.21 to $90.83. The price reported above reflects the weighted average sales price.
• F2: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
• F3: The shares were sold in multiple trades at prices ranging from $89.90 to $91.44. The price reported above reflects the weighted average sales price.
• F4: The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.